Tag: Epilepsy
-
Valproate in pregnancy falls to new low as safety measures take effect
The latest data on valproate in pregnancy A new update from the NHS Medicines and Pregnancy Dashboard, published on 25 September 2025, shows a continued drop in the use of sodium valproate by women of childbearing age and a very small number of pregnancies affected by the drug. Between October 2024 and March 2025, five…
-
Record-low NHS data show valproate prescriptions in pregnancy as more women stop before pregnancy
Key findings from the NHS Medicines and Pregnancy Dashboard New data released by NHS England reveal a continued decline in the number of women prescribed sodium valproate during pregnancy. Between October 2024 and March 2025, five women were prescribed valproate while pregnant, and notably, none of these women started the medication during pregnancy. In the…
-
Valproate in pregnancy at record low as NHS data show continued decline
Valproate in pregnancy dips to a record low, NHS data suggest The latest NHS Medicines and Pregnancy Dashboard, published on 25 September 2025, reveals a continued fall in the use of sodium valproate among women who are pregnant. In the six-month window from October 2024 to March 2025, only five women were prescribed valproate during…
-
Epilepsy in Portugal: New Study Finds Prevalence Near 10 per 1,000
Key findings from the EpiPort study A new epidemiological study, EpiPort, coordinated by the Liga Portuguesa Contra a Epilepsia (LPCE), projects that about 100,993 people in Portugal live with epilepsy. The research calculates a prevalence of 9.76 cases per 1,000 inhabitants, a figure that more than doubles the 4.4 per 1,000 identified in a previous…
-
Epilepsy in Portugal: Prevalence Nearly Doubles Previous Estimates
New EpiPort Study Finds Higher Epilepsy Prevalence in Portugal A national epidemiological study conducted by the Liga Portuguesa Contra a Epilepsia (LPCE) and titled EpiPort estimates that epilepsy affects about 100,993 people in Portugal, corresponding to a prevalence of 9.76 cases per 1,000 inhabitants. This figure is more than twice the prevalence identified in the…
-
Epilepsy in Portugal: Study Finds Nearly 100,000 People Affected
What the EpiPort study found A major epidemiological study released this week by the Liga Portuguesa Contra a Epilepsia (LPCE) updates how many people live with epilepsy in Portugal. The EpiPort study estimates about 100,993 individuals with epilepsy nationwide, translating to a prevalence of 9.76 cases per 1,000 inhabitants. This figure more than doubles the…
-
Josue Homawoo’s Terrifying Injury During Belgian Match
Shocking Incident on the Field In a chilling turn of events in the Belgian football league, Josue Homawoo, a former player for Dinamo Bucharest, faced a life-threatening situation during a match against Mechelen. The defender suffered a severe injury that left him unconscious, prompting immediate concerns for his health. The Moment of the Injury During…
-
The Importance of Rapid Diagnosis in Epilepsy
Understanding Epilepsy and Its Challenges Epilepsy is a neurological condition characterized by recurrent seizures, affecting millions worldwide. One of the significant challenges in managing epilepsy is the delay in diagnosis, particularly following a patient’s first seizure. A rapid diagnosis can lead to timely intervention, better treatment options, and improved quality of life for patients. The…
-
The Benefits of Early Diagnosis in Epilepsy
Understanding Epilepsy and Its Diagnosis Epilepsy is a neurological disorder characterized by unpredictable seizures, which can significantly impact a person’s daily life. The timely diagnosis of epilepsy is crucial, especially following a first seizure. Traditional pathways for diagnosis often lack standardization, leading to delays in treatment that can have a profound effect on patients and…